Skip to main content
logo
Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
37.65
+0.27 (0.72%)
Oct 30, 2025, 11:32 AM EDT - Market open

KNSA Revenue

Kiniksa Pharmaceuticals International, had revenue of $156.80M in the quarter ending June 30, 2025, with 44.34% growth. This brings the company's revenue in the last twelve months to $597.97M, up 55.68% year-over-year. In the year 2024, Kiniksa Pharmaceuticals International, had annual revenue of $423.24M with 56.60% growth.

Revenue (ttm)
$597.97M
Revenue Growth
+55.68%
P/S Ratio
4.58
Revenue / Employee
$1,898,327
Employees
315
Market Cap
2.79B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024423.24M152.98M56.60%
Dec 31, 2023270.26M50.08M22.74%
Dec 31, 2022220.18M181.64M471.24%
Dec 31, 202138.54M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

KNSA News

More News